Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Post by ValueCapon Oct 24, 2019 9:52am
230 Views
Post# 30263705

Vimovo US Royalty to stay at least a little while longer...

Vimovo US Royalty to stay at least a little while longer...Dr Reddy’s didn’t launch ‘at risk’ by October 20. The royalty for Q4 is likely still in tact.

Ongoing litigation continues for the other patents. Timeline to be revealed in the coming months. 

My thought is that Q1 royalty likely stays on because of this as well, given that these things usually take a couple months. But I’m no patent expert.

In the event that the patents do get upheld, it would be material upside for Nuvo 

https://www.bloomburton.com/research/NRI20191021.pdf
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities